Blackwell's Five-Minute Veterinary Consult Clinical Companion. Группа авторов

ETIOLOGY/PATHOPHYSIOLOGY SIGNALMENT/HISTORY CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS DIAGNOSTICS THERAPEUTICS COMMENTS Suggested Reading Chapter 11: Methamphetamine/ Amphetamine DEFINITION/OVERVIEW ETIOLOGY/PATHOPHYSIOLOGY SIGNALMENT/HISTORY CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS DIAGNOSTICS THERAPEUTICS COMMENTS Suggested Reading Chapter 12: Opioids DEFINITION/OVERVIEW ETIOLOGY/PATHOPHYSIOLOGY SIGNALMENT/HISTORY CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS DIAGNOSTICS THERAPEUTICS COMMENTS Suggested Reading Chapter 13: Selective Androgen (SARMS) and Estrogen Receptor (SERMS) Modulators DEFINITION/OVERVIEW ETIOLOGY/PATHOPHYSIOLOGY SIGNALMENT/HISTORY CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS DIAGNOSTICS THERAPEUTICS COMMENTS Suggested Reading Chapter 14: Synthetic Cannabinoids DEFINITION/OVERVIEW ETIOLOGY/PATHOPHYSIOLOGY SIGNALMENT/HISTORY CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS DIAGNOSTICS THERAPEUTICS COMMENTS Suggested Reading Drugs: Prescription Chapter 15: Antipsychotic Agents – Reserpine and Fluphenazine DEFINITION/OVERVIEW ETIOLOGY/PATHOPHYSIOLOGY SIGNALMENT/HISTORY CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS DIAGNOSTICS THERAPEUTICS COMMENTS Suggested Reading Chapter 16: Benzodiazepines DEFINITION/OVERVIEW ETIOLOGY/PATHOPHYSIOLOGY SIGNALMENT/HISTORY CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS DIAGNOSTICS THERAPEUTICS COMMENTS Suggested Reading Chapter 17: Beta₂ Agonists – Clenbuterol and Albuterol DEFINITION/OVERVIEW ETIOLOGY/PATHOPHYSIOLOGY SIGNALMENT/HISTORY CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS DIAGNOSTICS THERAPEUTICS COMMENTS Suggested Reading Chapter 18: Bisphosphonates DEFINITION/OVERVIEW ETIOLOGY/PATHOPHYSIOLOGY SIGNALMENT/HISTORY CLINICAL FEATURES DIFFERENTIAL DIAGNOSIS DIAGNOSTICS THERAPEUTICS COMMENTS Internet Resources Suggested Reading